FBTAX Holdings Information

FBTAX is a mutual fund with a total of 112 individual holdings. The top holdings are AbbVie stock at 14.74%, Gilead Sciences at 5.55%, Alnylam Pharmaceuticals at 4.64%, Spyre Therapeutics at 3.46%, and Insmed at 3.29%.

Total Holdings

112

Top 10 Percentage

47.84%

Asset Class

Equity

Fund Category

Health

Assets

2.20B

Forward PE Ratio

19.42

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	14.74%	1,289,880
2	GILD	Gilead Sciences, Inc.	5.55%	967,900
3	ALNY	Alnylam Pharmaceuticals, Inc.	4.64%	339,486
4	SYRE	Spyre Therapeutics, Inc.	3.46%	857,347
5	INSM	Insmed Incorporated	3.29%	680,300
6	ASND	Ascendis Pharma A/S	3.26%	269,225
7	ARGX	argenx SE	3.25%	77,200
8	DNTH	Dianthus Therapeutics, Inc.	3.23%	730,062
9	COGT	Cogent Biosciences, Inc.	3.22%	1,834,818
10	ORKA	Oruka Therapeutics, Inc.	3.19%	737,386
11	RVMD	Revolution Medicines, Inc.	3.00%	352,200
12	BIIB	Biogen Inc.	2.89%	294,100
13	AMGN	Amgen Inc.	2.22%	135,103
14	PCVX	Vaxcyte, Inc.	2.12%	801,529
15	MRNA	Moderna, Inc.	2.04%	640,800
16	AMLX	Amylyx Pharmaceuticals, Inc.	1.98%	2,433,200
17	RLAY	Relay Therapeutics, Inc.	1.57%	1,850,700
18	MBX	MBX Biosciences, Inc.	1.54%	614,600
19	VRDN	Viridian Therapeutics, Inc.	1.49%	1,782,464
20	VRTX	Vertex Pharmaceuticals Incorporated	1.44%	63,900
21	ELVN	Enliven Therapeutics, Inc.	1.32%	574,568
22	GPCR	Structure Therapeutics Inc.	1.29%	527,900
23	n/a	Fidelity Cash Central Fund	1.28%	28,208,744
24	ROIV	Roivant Sciences Ltd.	1.25%	776,700
25	KNSA	Kiniksa Pharmaceuticals International, plc	1.21%	417,600

Showing 25 of 112 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026